Nuclear dysfunction in aging and neurodegeneration.
Nuclear structure itself—not just protein clumping—drives neurodegeneration, opening new therapeutic paths distinct from traditional Alzheimer's drug approaches.
This Alzheimer's & Dementia review synthesizes emerging evidence that structural and functional changes in the nucleus are primary drivers of neuronal vulnerability in aging and neurodegenerative diseases, reviewing how nuclear lamina disruption, chromatin reorganization, nuclear pore complex dysfunction, and impaired DNA repair contribute to pathological neurodegeneration. The review proposes nuclear integrity as a targetable therapeutic axis for neurodegeneration, distinct from traditional protein aggregation-focused approaches.
What the study was
- Study design
- review
- Population
- Patients with AD, PD, and ALS; aging populations generally
- Category
- Other
- Maturity
- Exploratory
- Journal
- Alzheimers Dement
Why it surfaced
Mechanistic review in Alzheimer's & Dementia on nuclear dysfunction as primary aging/neurodegeneration driver; identifies novel therapeutic angles beyond traditional protein aggregation; relevant to aging watchlist; UTMB Mitchell Center group.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.